These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 81952)

  • 1. Vitamin-D analogues and renal function.
    Farrington K; VArghese Z; Moorhead JF
    Lancet; 1978 Oct; 2(8096):941. PubMed ID: 81952
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin-D analogues and renal function.
    Christiansen C; Christensen MS; Hartnack B; Melsen F; Transbøl I; Rødbro P
    Lancet; 1979 Jan; 1(8106):50-1. PubMed ID: 83502
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of vitamin D metabolites and analogues on renal function.
    Naik RB; Cundy T; Robinson BH; Russell RG; Kanis JA
    Nephron; 1981; 28(1):17-25. PubMed ID: 6894966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
    Christiansen C; Rødbro P; Christensen MS; Hartnack B; Transbøl I
    Lancet; 1978 Sep; 2(8092 Pt 1):700-3. PubMed ID: 80633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of small doses of 1,25-dihydroxycholecalciferol in renal osteodystrophy.
    Ahmed KY; Varghese Z; Wills MR; Meinhard EA; Moorhead JF
    Lancet; 1978 Mar; 1(8065):629-32. PubMed ID: 76168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of conventional doses of 1 alpha, 25-dihydroxycholecalciferol to correct hypocalcemia in a girl with idiopathic hypoparathyroidism.
    Chesney RW; Horowitz SD; Kream BE; Eisman JA; Hong R; DeLuca HF
    N Engl J Med; 1977 Dec; 297(23):1272-5. PubMed ID: 917074
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of vitamin D on remaining kidney function after chronic kidney failure in preservation period patient].
    Inaguma D; Tatematsu M; Shinjo H; Suzuki S; Mishima T; Inaba S; Nakamura T; Kato T
    Clin Calcium; 2005 Sep; 15 Suppl 1():152-5; discussion 155. PubMed ID: 16272649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitamin D metabolites as hormones in the regulation of calcium and phosphate metabolism].
    DeLuca HF; Kleiner-Bossaller A
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):329-37. PubMed ID: 4751457
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Fraser D; Kooh SW; Kind HP; Holick MF; Tanaka Y; DeLuca HF
    N Engl J Med; 1973 Oct; 289(16):817-22. PubMed ID: 4357855
    [No Abstract]   [Full Text] [Related]  

  • 10. New developments in pharmacology of vitamin D.
    Med Lett Drugs Ther; 1974 Feb; 16(3):15-6. PubMed ID: 4358446
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucocorticoids and intestinal absorption of calcium and phosphate.
    Caniggia A; Loré F; Nuti R; Vattimo A
    Adv Exp Med Biol; 1984; 171():91-100. PubMed ID: 6372407
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum concentrations of 24,25-dihydroxy vitamin D in different degrees of chronic renal failure.
    Weisman Y; Eisenberg Z; Leib L; Harell A; Shasha SM; Edelstein S
    Br Med J; 1980 Sep; 281(6242):712-3. PubMed ID: 7427411
    [No Abstract]   [Full Text] [Related]  

  • 13. Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?
    Kanis JA; Cundy T; Bartlett M; Smith R; Heynen G; Warner GT; Russell RG
    Br Med J; 1978 May; 1(6124):1382-6. PubMed ID: 647302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitamin D and renal failure (author's transl)].
    Fuss M; Corvilain J
    Rev Med Brux; 1981 Apr; 2(4):441-5. PubMed ID: 7291796
    [No Abstract]   [Full Text] [Related]  

  • 16. Impairment of renal function in patients on 1alpha-hydroxycholecalciferol.
    Winterborn MH; Mace PJ; Heath DA; White RH
    Lancet; 1978 Jul; 2(8081):150-1. PubMed ID: 78344
    [No Abstract]   [Full Text] [Related]  

  • 17. Requirements of vitamin D metabolites in patients with renal disease.
    Massry SG
    Am J Clin Nutr; 1980 Jul; 33(7):1530-5. PubMed ID: 6893103
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: vitamin-D metabolism in chronic renal failure.
    Wake CJ; Maddocks JL
    Lancet; 1975 Mar; 1(7905):516-7. PubMed ID: 46978
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
    N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
    Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
    N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.